Perennial Investment Advisors LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor acquired 5,358 shares of the company’s stock, valued at approximately $689,000.
A number of other large investors also recently modified their holdings of MKGAF. Frazier Financial Advisors LLC purchased a new position in shares of Merck KGaA in the 2nd quarter worth approximately $25,000. Rakuten Securities Inc. purchased a new stake in Merck KGaA during the 2nd quarter worth about $27,000. Solstein Capital LLC purchased a new stake in Merck KGaA in the 2nd quarter worth approximately $33,000. Delos Wealth Advisors LLC purchased a new position in Merck KGaA during the second quarter worth about $33,000. Finally, Burk Holdings LLC bought a new position in shares of Merck KGaA in the second quarter worth approximately $39,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 0.4%
OTCMKTS MKGAF opened at $164.58 on Thursday. The company has a market capitalization of $21.27 billion, a price-to-earnings ratio of 25.13 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The stock’s 50-day simple moving average is $163.19 and its two-hundred day simple moving average is $148.83. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
